Eurepa V 0.5/0.3 Mg Tablet (10 Tab)

EUREPA V 0.5/0.3 MG TABLET

EUREPA V 0.5/0.3 MG TABLET is an oral anti-diabetic medication manufactured by Torrent Pharmaceuticals Ltd..

Composition

• Active Ingredients: Each tablet contains Repaglinide 0.5 mg and Voglibose 0.3 mg.

Uses EUREPA V 0.5/0.3 MG TABLET is primarily used in the management of Type 2 Diabetes Mellitus. Its dual action mechanism effectively controls high blood sugar levels, particularly post-meal hyperglycemia (blood sugar spikes after eating). It is prescribed as an adjunct to diet and exercise when either voglibose or repaglinide alone, or other similar medicines, are unable to achieve adequate blood sugar control. The medication helps improve overall glycemic control and reduces the risk of long-term diabetes-related complications such as kidney damage, eye damage, nerve problems, and cardiovascular issues.

Dosage and Administration

• EUREPA V 0.5/0.3 MG TABLET should be taken orally as directed by a healthcare professional.
• It is generally recommended to take the tablet just before or immediately after main meals, typically 15 to 30 minutes before a main meal.
• Swallow the tablet whole with a glass of water; do not crush, chew, or break it.
• The exact dosage and frequency will be determined by your doctor based on your blood sugar levels and response to treatment.
• Do not stop taking the medicine without consulting your doctor, as abrupt discontinuation can lead to increased blood sugar levels and potential complications.
• If a dose is missed, do not take it between two meals. Wait until your next meal and take it as usual; do not take a double dose to compensate.

Side Effects Common side effects may include:

• Hypoglycemia (low blood sugar level)
• Bloating or flatulence
• Diarrhea
• Headache
• Fatigue or dizziness
• Stomach pain, abdominal pain, heartburn, nausea, and/or vomiting
• Skin rash, itching
• Fever, muscle pain, and/or tenderness
• Upper respiratory infections, flu-like symptoms, back pain, joint pain, restlessness, weakness, blurred vision

Most of these side effects are temporary and usually resolve on their own. However, if any of these symptoms worsen or persist for a longer duration, consult your doctor.

Precautions

• Contraindications: EUREPA V 0.5/0.3 MG TABLET is not recommended for individuals with Type 1 Diabetes Mellitus, severe kidney or liver disease, severe infections, or gastrointestinal obstructions.
• Allergies: Do not take this medicine if you are allergic to Repaglinide, Voglibose, or any of its components.
• Pregnancy and Breastfeeding: The use of EUREPA V 0.5/0.3 MG TABLET is generally not recommended during pregnancy or breastfeeding. Consult your doctor to discuss the risks and benefits.
• Alcohol: Avoid excessive alcohol consumption, as it can unpredictably affect blood sugar levels and increase the risk of hypoglycemia.
• Liver/Kidney Impairment: Exercise caution in patients with liver or kidney problems; dose adjustments may be necessary. It is not recommended in severe cases.
• Driving and Operating Machinery: Your ability to drive or operate machinery may be affected if your blood sugar levels become too low or too high. Use caution until you are certain you can safely perform such activities.
• Drug Interactions: Inform your doctor about all other medications, supplements, and herbal products you are taking, as interactions can occur. Particular caution is advised with other antidiabetic medicines (e.g., insulin, sulfonylureas) due to an increased risk of hypoglycemia.
• Age Restrictions: Generally not recommended for children under 18 years of age or individuals over 75 years without specific consultation with a doctor.
• Monitoring: Regular monitoring of blood sugar levels is recommended while taking this medicine.

Storage Store EUREPA V 0.5/0.3 MG TABLET in a cool, dry place away from direct sunlight. Keep it below 30°C.

Here are some frequently asked questions about EUREPA V 0.5/0.3 MG TABLET (10 TAB):

What is EUREPA V 0.5/0.3 MG Tablet used for?

EUREPA V 0.5/0.3 MG Tablet is used to manage Type 2 Diabetes Mellitus in adults, particularly for controlling high blood sugar levels after meals (post-prandial hyperglycemia). It is prescribed when diet, exercise, and other diabetes medicines alone have not been effective enough to control blood glucose levels.

How does EUREPA V 0.5/0.3 MG Tablet work?

This medicine contains two active ingredients: Repaglinide (0.5 mg) and Voglibose (0.3 mg). Repaglinide stimulates the pancreas to release more insulin, especially after meals, helping to transport glucose from the bloodstream into cells. Voglibose works in the intestines by blocking alpha-glucosidases, enzymes that break down complex carbohydrates into simple sugars. By inhibiting these enzymes, voglibose slows down the digestion and absorption of carbohydrates, preventing sudden spikes in blood glucose after eating.

What is the usual dosage for EUREPA V 0.5/0.3 MG Tablet?

The daily dose of EUREPA V 0.5/0.3 MG Tablet should be taken as prescribed by your doctor, as it varies based on your blood sugar levels and response to treatment. It is usually taken just before your main meals. Do not change your dose or stop taking this medicine without consulting your doctor.

What are the possible side effects of EUREPA V 0.5/0.3 MG Tablet?

Common side effects include hypoglycemia (low blood sugar), diarrhea, flatulence (excessive gas), abdominal pain, headache, dizziness, skin rash, and itching. Most of these side effects are temporary and generally resolve on their own. If any side effects are severe or persistent, consult your doctor.

Is EUREPA V 0.5/0.3 MG Tablet safe during pregnancy or breastfeeding?

Caution is advised during pregnancy and breastfeeding. EUREPA V 0.5/0.3 MG Tablet may be unsafe to use during pregnancy and is probably unsafe during breastfeeding. It is essential to consult your doctor if you are pregnant, planning to conceive, or breastfeeding before taking this medicine.

Can EUREPA V 0.5/0.3 MG Tablet be taken with other medications?

EUREPA V 0.5/0.3 MG Tablet can interact with various medicines. Taking it with other antidiabetic medicines like insulin or sulfonylureas may increase the risk of hypoglycemia. Antibiotics (e.g., clarithromycin, erythromycin), antifungals (e.g., ketoconazole, fluconazole), and certain heart medicines (e.g., calcium channel blockers like diltiazem and verapamil) may alter its effectiveness. Other medicines like steroids, antiplatelet medication (e.g., clopidogrel), and NSAIDs (e.g., aspirin) may also interact. Always inform your doctor about all medications, including prescribed, non-prescribed, herbal medicines, and dietary supplements, you are taking.

What precautions should be taken while using EUREPA V 0.5/0.3 MG Tablet?

Exercise caution if you have kidney or liver impairment, as dose adjustments may be needed. This medicine is not suitable for Type 1 diabetes. Avoid excessive alcohol consumption as it can unpredictably affect blood sugar levels and increase the risk of hypoglycemia. It is generally not recommended for children under 18 or adults over 75 years of age without consulting a doctor. A healthy diet and regular exercise are crucial alongside this medication.

What happens if a dose of EUREPA V 0.5/0.3 MG Tablet is missed?

If you miss a dose, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for the missed one.

How should EUREPA V 0.5/0.3 MG Tablet be stored?

Store EUREPA V 0.5/0.3 MG Tablet at room temperature (below 30°C). Keep it away from direct heat, light, and moisture, and store it in its original packaging. Ensure it is kept out of reach of children and pets. Do not use the medicine after the expiry date printed on the package.